
IgAN is a progressive, rare kidney disease in which the immune system attacks the kidneys, often causing glomerular inflammation and…
Presently, India imposes 10 percent tariff on Pharma imports from the United States. The US doesn’t impose any tariff on…
The company said it will expand its weight-loss offerings with branded versions of Lilly’s tirzepatide.
Jefferies maintains that companies with mixed revenue streams, such as specialty pharma, biosimilars, and inhalers, may face some impact.
The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.
The US report criticizes India’s drug price controls on medical devices like stents and knee implants, citing concerns over inflation…
Nipah virus belongs to the Paramyxovirus family. It is one of the deadliest pathogens known to infect humans.
GlobalData’s Emerging Market Outsourcing report reveals that this push for domestic production could lead to increased production costs and inflationary…
Drugmakers have argued that tariffs could increase the chance of drug shortages and reduce access for patients.
Lilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products claiming to…
Managing both conditions primarily involves lowering intraocular pressure to prevent further complications.
According to IQVIATM sales data for the 12-month period ending January 2025, the Vancomycin Hydrochloride for Injection USP, 750 mg/vial,…
The National List of Essential Medicines includes crucial medicines used in different scenarios, including drugs used for anaesthesia, antiallergics, neurological…
These medicines are prescribed to treat conditions like chest infections such as pneumonia, metabolic disorder, high blood sugar etc.
Every suicide is a tragedy that affects families, communities and entire countries and it also has long-lasting effects on the…
Qfitlia does not replace the missing clotting factor. Rather, it reduces the amount of a protein called antithrombin, leading to…
The FDA reviewed this test under the FDA’s De Novo premarket review pathway, a regulatory pathway for low- to moderate-risk…
The life-saving devices will see prices rise by nearly Rs 700 in some cases as the MRP is adjusted for…